THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | SC 13D/A:超过5%持股股东披露文件(修正)-Havencrest Healthcare Partners GP, LLC(12.04%),Havencrest Healthcare Partners, L.P.(11.93%)等
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-股东 Havencrest Healthcare Partners, L.P.
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 BARASCH RICHARD A
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Hively Brad
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Johnson Karen Marie
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Kaushal Mohit
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Ling Gabriel
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 McGeorge Anne
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 O'Meara Maeve
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Pacala Mark L
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-首席财务官 Shah Mihir
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-首席运营官 Castle Jeremy
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Hively Brad
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-首席执行官 Virnich Daniel
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-高管 Podnos Yale
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-董事 Hively Brad
THE ONCOLOGY INSTITUTE INC C/WTS 15/11/2026 (TO PUR COM) | 4:持股变动声明-高管 Podnos Yale
暂无数据